Antidrug antibodies in NIU are seen with adalimumab but not infliximab

• Posted on: May 25 2023
• By: Saratoga Opthalmology
• Leave a response

Tumor necrosis factor-alpha inhibitors adalimumab and infliximab are common therapies for noninfectious uveitis (NIU), but the presence of antidrug antibodies could result in lower circulating drug levels.
Source: AAO

Posted in: Uncategorized